Risk factors and prognosis of perioperative hidden blood loss in hip replacement patients

doi:10.3969/j.issn.2095-4344.2014.13.007

Abstract

Abstract:

BACKGROUND: Hidden blood loss, a frequent occurrence following artificial joint replacement, greatly affects the recovery from total hip arthroplasty. Many factors have been shown to have a correlation with the hidden blood loss, but the specific mechanism is not yet clear.
OBJECTIVE: To investigate the correlation of patients’ baseline (sex, age, underlying disease, obesity), prosthesis types, surgical time with hidden blood loss following total hip arthroplasty, as well as the association between hidden blood loss and prognosis.
METHODS: Ninety patients undergoing total hip arthroplasty were enrolled in this study. Using Gross formula, we calculated the total blood loss according to height, weight, and pre- and post-operative hematocrit, and subtracted the dominant loss of blood to get the quantitative value of hidden blood loss. According to the criterion, the 90 patients were divided to two groups: group I: volume of hidden blood loss > 480 mL, group II: volume of hidden blood loss < 480 mL. Then we analyze the difference in the gender, age, underlying disease, type of prosthesis, surgical time between the two groups, and whether there was a correlation between these factors and hidden blood loss. All the patients were followed for 1 year. Perioperative complications and survival curves were observed and monitored in the two groups.
RESULTS AND CONCLUSION: There were 39 patients in the group I, including 64.1% males, 64.1% hypertension patients, 35.9% diabetic patients, 7.7% patients receiving cement prosthesis; while, there were 51 patients in the group II, including 37.3% males, 25.5% hypertension patients, 5.9% diabetic patients, 35.3% patients receiving cemented prosthesis, showing a significant difference between the two groups. Based on these experimental findings, age, hypertension, diabetes mellitus, type of prosthesis were shown to be factors independently associated with hidden blood loss; however, obesity and smoking exhibited no correlation with hidden blood loss. In addition, a statistical difference in the survival rate was found at admission and during the 1-year follow-up.

中国组织工程研究杂志出版内容重点：人工关节；骨植入物；脊柱；骨折；内固定；数字化骨科；组织工程

全文链接：

Key words: arthroplasty, replacement, hip, postoperative hemorrhage, obesity, hip prosthesis, blood transfusion

CLC Number:

R318

Li Shao-fei, Guo Ting, Zhao Jian-ning, Bao Ni-rong. Risk factors and prognosis of perioperative hidden blood loss in hip replacement patients[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(13): 2006-2011.

Figures/Tables 2

References

[1] Bozic KJ, Kurtz SM, Lau E, et al. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91(1):128-133.

[2] Berry DJ, Harmsen WS, Cabanela ME, et al. Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am 2002;84-A(2):171-176.

[3] Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet 2007;370(9597): 1508-1511.

[4] Cherian JJ, Kapadia BH, Issa K,et al Preoperative Blood Management Strategies for Total Hip Arthroplasty.Surg Technol Int. 2013;9(30):23-37.

[5] Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. J Bone Joint Surg Br. 2006;88(8):1053-1059.

[6] Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004;86(4):561-565.

[7] Li B, Wen Y, Liu D, et al. The effect of knee position on blood loss and range of motion following total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2012;20(3):594-599.

[8] Liu X, Zhang X, Chen Y, et al. Hidden blood loss after total hip arthroplasty. J Arthroplasty. 2011;26(7):1100-1105.

[9] 丛宇,赵建宁,包倪荣,等.隐性失血对全髋关节置换术后功能恢复影响的临床观察[J].中国骨伤,2011,24(6):466-468.

[10] Meiser A, Casagranda O, Skipka G, et al. Quantification of blood loss. How precise is visual estimation and what does its accuracy depend on?. Anaesthesist. 2001;50(1):13-20.

[11] Rauey FE,Berta D, Binns V, et al. One intraoperative dose of tranex- amic acid for patients having primary hip or knee arthroplasty. Clini Orthop Related Res. 2010;468(7): 1905-1911.

[12] Bao N, Zhou L, Cong Y, et al. Free fatty acids are responsible for the hidden blood loss in total hip and knee arthroplasty. Med Hypotheses. 2013;81(1):104-107.

[13] 周一新.骨科标准新突破手术技术指导规范-《人工髋、膝关节置换术》解读[J].中国卫生标准管理,2011,2(04):72-74.

[14] 中华医学会会骨科学分会．预防骨科大手术深静脉血栓形成指南(草案)[J].中国矫形外科杂志.2009.17(2):118.

[15] Piscitelli P, Iolascon G, Innocenti M, et al. Painful prosthesis: approaching the patient with persistent pain following total hip and knee arthroplasty. Clin Cases Miner Bone Metab. 2013; 10(2):97-110.

[16] Sehat KR, Evans RL, Newman JH. dden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004;86(4):561-565.

[17] Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008;17(3):370-374.

[18] Bell TH, Berta D, Ralley F, et al. Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg. 2009;52(4):295-301.

[19] Prasad N, Padmanabhan V, Mullaji A. Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop. 2007;31(1): 39-44.

[20] del Trujillo MM, Carrero A, Muñoz M. The utility of the perioperative autologous transfusion system OrthoPAT in total hip replacement surgery: a prospective study. Arch Orthop Trauma Surg. 2008;128(10):1031-1038.

[21] Loš?ák J, Galo J, Ml??chová D. Multivariate Analysis of Blood Loss during Primary Total Hip or Knee Arthroplasty. Acta Chir Orthop Traumatol Cech. 2013;80(3):219-225.

[22] 庞向华,欧阳建江,欧兆强,等. 隐性失血与全髋关节置换术后髋关节功能的相关性及影响因素[J]. 广东医学,2013,34(3): 420-422.

[23] 冯树雄,陈小萍,曾健聪,等. 半髋关节置换术后隐性失血的相关因素分析[J]. 国际医药卫生导报,2013,19(14):2158-2160.

[24] 刘志刚,张上上,陈如见,等. 全髋关节置换后的隐性失血[J]. 中国组织工程研究,2013,17(13):2305-2312.

[25] Sehat KR,Evans R,Newman JH.How much blood is really lost in total knee arthroplasty?Correct blood loss management should take hidden loss into account.Knee.2000;7(3):151- 155.

[26] Li J, Zhou Y, Jing J, et al. parison of effects of two anticoagulants on hidden blood loss after total hip arthroplasty. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013;27(4):432- 435.

[27] Noordin S, Waters TS, Garbuz DS, et al. Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty. Clin Orthop Relat Res. 2011;469(2):541-546.

[28] Hull RD, Liang J, Brant R. Pooled analysis of trials may, in the presence of heterogeneity inadvertently lead to fragile conclusions due to the importance of clinically relevant variables being either hidden or lost when the findings are pooled. Thromb Res. 2010;126(3):164-165.

[29] Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth. 2011;106(1):13-22.

[30] Parvizi J, Chaudhry S, Rasouli MR, et al. Who needs autologous blood donation in joint replacement? J Knee Surg. 2011;24(1):25-31.

[31] Guerin S, Collins C, Kapoor H, et al. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Transfus Med. 2007;17(1):37-43.

[32] Chang CW, Wu PT, Yang CY. Blood loss after minimally invasive total knee arthroplasty: effects of imageless navigation. Kaohsiung J Med Sci. 2010 ;26(5):237-243.

[33] Pietsch M, Djahani O, Zweiger Ch, et al. Custom-fit minimally invasive total knee arthroplasty: effect on blood loss and early clinical outcomes. Knee Surg Sports Traumatol Arthrosc. 2013; 21(10):2234-2240.

[34] Marulanda GA, Ulrich SD, Seyler TM, et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008 ;5(2):125-131.

[35] Atay EF, Güven M, Alt?nta? F, et al. Allogeneic blood transfusion decreases with postoperative autotransfusion in hip and knee arthroplasty. Acta Orthop Traumatol Turc. 2010; 44(4):306-312.

[36] Young SW, Marsh DJ, Akhavani MA, et al. Attitudes to blood transfusion post arthroplasty surgery in the United Kingdom: a national survey. Int Orthop. 2008;32(3):325-329.

[37] 孙伟,李子荣.人工关节置换术围手术期的血液管理[J].中华外科杂志, 2004,42(4):244-247。

[38] Noticewala MS, Nyce JD, Wang W, et al. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty. 2012;27(6):961-967.

[39] Keating EM, Callaghan JJ, Ranawat AS, et al. Keating EM, Callaghan JJ, Ranawat AS, et al. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strength. J Arthroplasty. 2007;22(3):325-333. J Arthroplasty. 2007;22(3):325-333.

[40] MoonenAF, Thomassen BJ, KnoorsNT, et al.Pre-operative injections of epoetin-alpha versus post operative retransfusion of autologousshed blood in total hip and knee replacement: a prospective randomised clinical trial. J Bone Joint Surg Br. 2008;90(8):1079-1083.

[41] Chen LL, Wang WC, Mao XZ, et al. Evaluation and treatment of hemorrhage after hip and knee arthroplasty in the aged. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007;32(2): 316-319.